What was the overall market valuation of the pharmacy benefit-management-services market in 2024?

The overall market valuation was $31.9 Billion in 2024. Read More

What is the projected market valuation for the pharmacy benefit-management-services market by 2035?

The projected valuation for 2035 is $62.04 Billion. Read More

What is the expected CAGR for the pharmacy benefit-management-services market during the forecast period 2025 - 2035?

The expected CAGR during the forecast period 2025 - 2035 is 6.23%. Read More

Which segment had the highest valuation in 2024 for pharmacy benefit-management-services?

Formulary Management had the highest valuation at $8.77 Billion in 2024. Read More

What are the key players in the pharmacy benefit-management-services market?

Key players include CVS Health, Express Scripts, OptumRx, Humana, Cigna, Prime Therapeutics, MedImpact, and EnvisionRx. Read More

What is the valuation of the Drug Utilization Review segment in 2024?

The valuation of the Drug Utilization Review segment was $7.96 Billion in 2024. Read More

How much is the Health Plans segment projected to be worth by 2035?

The Health Plans segment is projected to be worth $20.75 Billion by 2035. Read More

What is the valuation of Fully-Managed Services in 2024?

Fully-Managed Services had a valuation of $12.76 Billion in 2024. Read More

Which service provider segment is expected to grow the most by 2035?

Health Insurance Companies are expected to grow the most, reaching $24.0 Billion by 2035. Read More

What was the valuation of the Employers segment in 2024?

The Employers segment was valued at $6.39 Billion in 2024. Read More

Germany Pharmacy Benefit Management Services Market

ID: MRFR/Pharma/48951-HCR

200 Pages

Vikita Thakur

Last Updated: April 06, 2026

Germany Pharmacy Benefit Management Services Market Research Report By Service Type (Claims Management, Formulary Management, Drug Utilization Review, Medication Therapy Management), By End User (Pharmacies, Health Plans, Employers, Public Sector), By Service Provider (Standalone Pharmacy Benefit Managers, Health Insurance Companies, Integrated Health Systems) and By Operating Model (Fully-Managed Services, Pass-Through Services, Hybrid Services) -Forecast to 2035

Germany Pharmacy Benefit Management Services Market Infographic

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Life Sciences, BY Type (USD Billion)
  1. 4.1.1 Claims Management
  2. 4.1.2 Formulary Management
  3. 4.1.3 Drug Utilization Review
  4. 4.1.4 Medication Therapy Management
2. 4.2 Life Sciences, BY End User (USD Billion)
  1. 4.2.1 Pharmacies
  2. 4.2.2 Health Plans
  3. 4.2.3 Employers
  4. 4.2.4 Public Sector
3. 4.3 Life Sciences, BY Service Provider (USD Billion)
  1. 4.3.1 Standalone Pharmacy Benefit Managers
  2. 4.3.2 Health Insurance Companies
  3. 4.3.3 Integrated Health Systems
4. 4.4 Life Sciences, BY Operating Model (USD Billion)
  1. 4.4.1 Fully-Managed Services
  2. 4.4.2 Pass-Through Services
  3. 4.4.3 Hybrid Services
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Life Sciences
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Life Sciences
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 CVS Health (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Express Scripts (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 OptumRx (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Humana (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Cigna (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Prime Therapeutics (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 MedImpact (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 EnvisionRx (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 GERMANY MARKET ANALYSIS BY TYPE
3. 6.3 GERMANY MARKET ANALYSIS BY END USER
4. 6.4 GERMANY MARKET ANALYSIS BY SERVICE PROVIDER
5. 6.5 GERMANY MARKET ANALYSIS BY OPERATING MODEL
6. 6.6 KEY BUYING CRITERIA OF LIFE SCIENCES
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF LIFE SCIENCES
9. 6.9 DRIVERS IMPACT ANALYSIS: LIFE SCIENCES
10. 6.10 RESTRAINTS IMPACT ANALYSIS: LIFE SCIENCES
11. 6.11 SUPPLY / VALUE CHAIN: LIFE SCIENCES
12. 6.12 LIFE SCIENCES, BY TYPE, 2024 (% SHARE)
13. 6.13 LIFE SCIENCES, BY TYPE, 2024 TO 2035 (USD Billion)
14. 6.14 LIFE SCIENCES, BY END USER, 2024 (% SHARE)
15. 6.15 LIFE SCIENCES, BY END USER, 2024 TO 2035 (USD Billion)
16. 6.16 LIFE SCIENCES, BY SERVICE PROVIDER, 2024 (% SHARE)
17. 6.17 LIFE SCIENCES, BY SERVICE PROVIDER, 2024 TO 2035 (USD Billion)
18. 6.18 LIFE SCIENCES, BY OPERATING MODEL, 2024 (% SHARE)
19. 6.19 LIFE SCIENCES, BY OPERATING MODEL, 2024 TO 2035 (USD Billion)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 Germany MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.2.2 BY END USER, 2025-2035 (USD Billion)
  3. 7.2.3 BY SERVICE PROVIDER, 2025-2035 (USD Billion)
  4. 7.2.4 BY OPERATING MODEL, 2025-2035 (USD Billion)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

Germany Life Sciences Market Segmentation

Life Sciences By Type (USD Billion, 2025-2035)

Claims Management
Formulary Management
Drug Utilization Review
Medication Therapy Management

Life Sciences By End User (USD Billion, 2025-2035)

Pharmacies
Health Plans
Employers
Public Sector

Life Sciences By Service Provider (USD Billion, 2025-2035)

Standalone Pharmacy Benefit Managers
Health Insurance Companies
Integrated Health Systems

Life Sciences By Operating Model (USD Billion, 2025-2035)

Fully-Managed Services
Pass-Through Services
Hybrid Services

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”